pubmed-article:21048039 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C0334246 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C0460004 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C1414313 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C0178655 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C0995188 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C1708063 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:21048039 | lifeskim:mentions | umls-concept:C0681890 | lld:lifeskim |
pubmed-article:21048039 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:21048039 | pubmed:dateCreated | 2011-4-27 | lld:pubmed |
pubmed-article:21048039 | pubmed:abstractText | The phase III EXTREME study demonstrated that combining cetuximab with platinum/5-fluorouracil (5-FU) significantly improved overall survival in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) compared with platinum/5-FU alone. The aim of this investigation was to evaluate elevated tumor EGFR gene copy number as a predictive biomarker in EXTREME study patients. | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:language | eng | lld:pubmed |
pubmed-article:21048039 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21048039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21048039 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21048039 | pubmed:month | May | lld:pubmed |
pubmed-article:21048039 | pubmed:issn | 1569-8041 | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:RotterHH | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:BenassiGG | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:RemenárEE | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:RiveraFF | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:StörkelSS | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:VermorkenJ... | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:KaweckiAA | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:LicitraLL | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:StromFF | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:HittRR | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:ErfánJJ | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:SengerSS | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:MesiaRR | lld:pubmed |
pubmed-article:21048039 | pubmed:author | pubmed-author:ZabolotnyyDD | lld:pubmed |
pubmed-article:21048039 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21048039 | pubmed:volume | 22 | lld:pubmed |
pubmed-article:21048039 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21048039 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21048039 | pubmed:pagination | 1078-87 | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:meshHeading | pubmed-meshheading:21048039... | lld:pubmed |
pubmed-article:21048039 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21048039 | pubmed:articleTitle | Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study. | lld:pubmed |
pubmed-article:21048039 | pubmed:affiliation | Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy. | lld:pubmed |
pubmed-article:21048039 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21048039 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |